Guardian Pharmacy Services Inc. (GRDN)
NYSE NYSE Primary Summary
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago.
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO, President & Director David Morris - CFO, Executive VP & Director Conference Call Participants John Ransom - Raymond James & Associates, Inc., Research Division David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, everyone, and welcome to Guardian Pharmacy's Third Quarter Earnings Call. [Operator Instructions] I will now hand the call over to Ashley Stockton.
Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardian Pharmacy Services Inc. (GRDN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Guardian Pharmacy Services Inc. ever had a stock split?
Guardian Pharmacy Services Inc. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Fred P. Burke CEO | NYSE Exchange | 40145W101 CUSIP |
| US Country | 3,400 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Guardian Pharmacy Services, Inc. is a specialized company that focuses on providing a broad spectrum of pharmacy services specifically tailored for long-term health care facilities (LTCFs) across the United States. Founded in 2003 and headquartered in Atlanta, Georgia, Guardian Pharmacy operates with the vision of enhancing the quality of care for residents in lower acuity LTCFs, which include assisted living facilities, behavioral health facilities, and group homes. By integrating technology into their services, they seek to ensure that each resident receives personalized clinical services, along with efficient drug dispensing and administration solutions.
Products and Services
- Guardian Compass
- GuardianShield Programs for LTCFs
A cornerstone tool developed by Guardian Pharmacy Services, the Guardian Compass is designed to empower local pharmacies with robust dashboards derived from comprehensive data analytics stored in the company's data warehouse. This specialized resource assists pharmacies in planning, tracking, and optimizing their operational processes, ensuring that they can provide the highest level of service to LTCFs. Through the analytical insights offered, pharmacies are better equipped to manage their inventory, streamline their dispensing procedures, and enhance overall patient care.
Specifically tailored for Long-Term Care Facilities, the GuardianShield Programs serve as a suite of services aimed at bolstering the safety and efficacy of medication management within these settings. This includes providing comprehensive clinical support to facility staff, ensuring that medication administrations are accurate and in compliance with regulatory standards, and implementing safeguard measures to prevent medication errors. The program not only emphasizes the importance of drug safety but also focuses on customizing medication management protocols to meet the unique needs of each facility, thereby promoting better health outcomes for residents.
Contact Information
